Continuous subcutaneous apomorphine infusion to improve comfort in advanced degenerative Parkinsonian syndrome patients: a retrospective descriptive study in a home-based setting
The findings point toward a potential benefit of CSAI delivered through a HaH program on symptom and comfort improvement in advanced PD and MSA patients. This positive effect was suggested in patients facing a life-threatening event compromising the oral route, whether or not they were in the immediate end-of-life phase.
Authors
- Louise Marine Harlé
- Clément Leclaire (ORCID: https://orcid.org/0000-0001-9162-2574)
- D. Grabli
- Simon Singovski
- Jérémie Zerbit
Institutions
- Sorbonne Université (FR)
- Université Sorbonne Paris Nord (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Pitié-Salpêtrière Hospital (FR)
- Geneva College (US)
Publication Details
- Journal
- Parkinsonism & Related Disorders
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1016/j.parkreldis.2026.108214
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00